CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-04 | Davis Todd C Director | Grant or award | +7,375 | 125,905 | ||
| 2022-08-04 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +44,224 | 44,224 | ||
| 2021-12-22 | Davis Todd C Director | Gift | −1,470 | 118,530 | ||
| 2021-06-16 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +15,097 | 15,097 | ||
| 2020-06-08 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +65,700 | 65,700 | ||
| 2020-04-28 | Davis Todd C Director | Sale | −60,000 | $3.28 | $197K | 120,000 |
| 2019-11-18 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +54,720 | 54,720 | ||
| 2019-11-18 | Davis Todd C Director | Grant or award · Stock Option (right to buy) | +54,720 | 54,720 |
Page 1 of 1 · 8 trades